Drug Makers Knew of Actos Bladder Cancer Risk, Lawsuits Say
By Matt O’Donnell
An Actos bladder cancer lawsuit has been filed on behalf of four men who claim the diabetes drug Actos (pioglitazone) caused their bladder cancer. Their bundled lawsuit joins more than 800 Actos bladder cancer lawsuits consolidated in federal court against drug maker Takeda Pharmaceuticals, its subsidiaries and Eli Lilly, alleging they knew of the drug’s cancer risks but hid this information from the public. Two of the men are joined by their wives in the case.According to the men’s Actos bladder cancer lawsuit, filed last week in the U.S. District Court of Louisiana, the Defendants willfully misled the men, their doctors and the general public by aggressively marketing Actos as safe, even though the Defendants knew or should have known that Actos was linked to bladder cancer. Their Actos injury lawsuit is seeking compensatory damages from Takeda and Eli Lilly for the pain and suffering they endured. The Court will unbundle the lawsuit and assign each case its own case number, according to their Actos injury attorney.
Updated August 22nd, 2012
{loadposition content_postads}
All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.
Top Class Actions Legal Statement